Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sharon Chinthrajah

Showing results (1-10 of 164) with videos related to

Pageof 17
Sort By:
Frontiers in Immunology|September 25, 2020
Editorial: Insights Into the Etiology, Prevention, and Treatment of Food AllergyMichiko Oyoshi, R Sharon Chinthrajah
Journal of Hospital Medicine|June 7, 2007
Severe tophaceous goutJulie Chen, Sharon Chinthrajah, Paul Aronowitz
The Journal of Allergy and Clinical Immunology|November 8, 2020
Omalizumab in "non-IgE-mediated" diseasesR Sharon Chinthrajah, Stephen J Galli
Allergy|April 10, 2019
Legends of Allergy: Stephen J. GalliMindy Tsai, Sharon Chinthrajah, Kari C Nadeau
Human Vaccines & Immunotherapeutics|November 27, 2014
Oral immunotherapy for the treatment of food allergyPhilippe Begin, R Sharon Chinthrajah, Kari C Nadeau
The New England Journal of Medicine|May 29, 2024
Omalizumab for the Treatment of Multiple Food Allergies. ReplyRobert A Wood, Alkis Togias, R Sharon Chinthrajah
The Journal of Allergy and Clinical Immunology|September 1, 2022
ReplyR Sharon Chinthrajah, Alkis Togias, Robert A Wood, et al.
The Journal of Allergy and Clinical Immunology|November 22, 2023
The promise of sublingual and other immunotherapy options for infants and toddlers with food allergyAikaterini Anagnostou, Julia E M Upton, R Sharon Chinthrajah
Current Allergy and Asthma Reports|January 18, 2020
New Developments in Non-allergen-specific Therapy for the Treatment of Food AllergyAndrew Long, Matteo Borro, Vanitha Sampath, et al.
Clinical and Molecular Allergy : CMA|April 14, 2021
H2-antagonist in IgE-mediated type I hypersensitivity reactions: what literature says so far?Matteo Borro, Simone Negrini, Andrew Long, et al.
Pageof 17

Showing results (1-10 of 164) with videos related to

Sort By:
Pageof 17
Frontiers in Immunology|September 25, 2020
Editorial: Insights Into the Etiology, Prevention, and Treatment of Food AllergyMichiko Oyoshi, R Sharon Chinthrajah
Journal of Hospital Medicine|June 7, 2007
Severe tophaceous goutJulie Chen, Sharon Chinthrajah, Paul Aronowitz
The Journal of Allergy and Clinical Immunology|November 8, 2020
Omalizumab in "non-IgE-mediated" diseasesR Sharon Chinthrajah, Stephen J Galli
Allergy|April 10, 2019
Legends of Allergy: Stephen J. GalliMindy Tsai, Sharon Chinthrajah, Kari C Nadeau
Human Vaccines & Immunotherapeutics|November 27, 2014
Oral immunotherapy for the treatment of food allergyPhilippe Begin, R Sharon Chinthrajah, Kari C Nadeau
The New England Journal of Medicine|May 29, 2024
Omalizumab for the Treatment of Multiple Food Allergies. ReplyRobert A Wood, Alkis Togias, R Sharon Chinthrajah
The Journal of Allergy and Clinical Immunology|September 1, 2022
ReplyR Sharon Chinthrajah, Alkis Togias, Robert A Wood, et al.
The Journal of Allergy and Clinical Immunology|November 22, 2023
The promise of sublingual and other immunotherapy options for infants and toddlers with food allergyAikaterini Anagnostou, Julia E M Upton, R Sharon Chinthrajah
Current Allergy and Asthma Reports|January 18, 2020
New Developments in Non-allergen-specific Therapy for the Treatment of Food AllergyAndrew Long, Matteo Borro, Vanitha Sampath, et al.
Clinical and Molecular Allergy : CMA|April 14, 2021
H2-antagonist in IgE-mediated type I hypersensitivity reactions: what literature says so far?Matteo Borro, Simone Negrini, Andrew Long, et al.
Pageof 17